Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth

Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth

Ovarian cancer is the deadliest gynecological malignancy. Though most patients enter remission following initial interventions, relapse is common and often fatal. Accordingly, there is a substantial need for ovarian cancer therapies that prevent relapse. Following remission generated by surgical deb...

Full description

Bibliographic Details
Main Authors: Courtney T. Stump, Gregory Ho, Chenkai Mao, Frank A. Veliz, Veronique Beiss, Jennifer Fields, Nicole F. Steinmetz, Steven Fiering
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
ovarian cancer
immunotherapy
vaccine
CPMV
T cell-dependent
adjuvant
Online Access:https://www.mdpi.com/2072-6694/13/4/627

Internet

https://www.mdpi.com/2072-6694/13/4/627

Similar Items